These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23284049)

  • 1. Replication of Epstein-Barr viral DNA.
    Hammerschmidt W; Sugden B
    Cold Spring Harb Perspect Biol; 2013 Jan; 5(1):a013029. PubMed ID: 23284049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Epstein-Barr Virus Induces the Reorganization of Cellular Chromatin.
    Rosemarie Q; Kirschstein E; Sugden B
    mBio; 2023 Feb; 14(1):e0268622. PubMed ID: 36625581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Hammerschmidt W; Sugden B
    Cell; 1988 Nov; 55(3):427-33. PubMed ID: 2846181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
    Tsurumi T
    Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin.
    Little RD; Schildkraut CL
    Mol Cell Biol; 1995 May; 15(5):2893-903. PubMed ID: 7739569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal lengths for DNAs encapsidated by Epstein-Barr virus.
    Bloss TA; Sugden B
    J Virol; 1994 Dec; 68(12):8217-22. PubMed ID: 7966614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
    Kalla M; Göbel C; Hammerschmidt W
    J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.
    Schepers A; Ritzi M; Bousset K; Kremmer E; Yates JL; Harwood J; Diffley JF; Hammerschmidt W
    EMBO J; 2001 Aug; 20(16):4588-602. PubMed ID: 11500385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.
    Nanbo A; Sugden A; Sugden B
    EMBO J; 2007 Oct; 26(19):4252-62. PubMed ID: 17853891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.